Understanding Osteoporosis
Osteoporosis is a progressive condition where bone mineral density decreases, compromising skeletal strength and increasing fracture susceptibility. The World Health Organization defines it clinically as a T-score of −2.5 or lower on bone density imaging, reflecting a departure from healthy young adult bone mass.
The disease develops silently without symptoms until a fracture occurs. Even minor trauma—a fall from standing height or a bump—can cause significant breaks in compromised bones. This is why risk assessment matters: identifying vulnerable individuals allows for early intervention before fractures happen.
Two pathways lead to osteoporosis: primary osteoporosis stems from age-related bone loss and hormonal decline (especially post-menopausal estrogen deficiency in women), while secondary osteoporosis results from medical conditions, medications, or lifestyle factors that accelerate bone turnover.
Key Risk Factors and Contributors
Several modifiable and non-modifiable factors influence osteoporosis risk:
- Age and sex: Bone density peaks in the early 30s and declines thereafter. Women lose bone rapidly in the decade following menopause due to oestrogen withdrawal.
- Body weight: Lower body mass reduces skeletal loading and provides less mechanical stimulus for bone maintenance. Being significantly underweight is a documented risk factor.
- Ethnicity: Caucasian and Asian populations have lower peak bone mass than African populations, translating to higher fracture risk at equivalent density levels.
- Fracture history: Prior fragility fractures (breaks from minimal trauma) indicate bone quality issues beyond density alone.
- Rheumatoid arthritis: Systemic inflammation and reduced mobility accelerate bone loss.
- Chronic obstructive pulmonary disease: COPD correlates with increased fracture risk through systemic inflammation and reduced activity.
- Lifestyle factors: Smoking impairs bone formation; excessive alcohol disrupts mineral absorption and balance; sedentary behaviour removes mechanical loading stimulus.
Osteoporosis Risk Scoring Methods
Three validated scoring systems quantify fracture risk based on clinical and demographic data. The OST applies universally; SCORE targets women; MORES adds COPD assessment for men.
OST = ((Weight in kg × 0.45359237) − Age in years) ÷ 5
SCORE = Ethnicity + Oestrogen therapy + Fractures + Rheumatoid arthritis + (3 × Age ÷ 10) − (Weight ÷ 10)
MORES = Age + Weight + COPD status (adjusted coefficients)
Weight— Body mass in kilograms (or converted from pounds); used as a proxy for skeletal loading and bone strengthAge— Age in completed years; accounts for cumulative bone loss over the lifespanEthnicity— Categorical factor reflecting baseline bone mass variation; contributes to SCORE onlyOestrogen therapy— History of hormone replacement therapy; protective factor in postmenopausal womenFractures— Count of prior fragility fractures; indicator of underlying bone qualityRheumatoid arthritis— Presence of RA diagnosis; inflammatory marker included in SCORECOPD status— Chronic obstructive pulmonary disease presence; component of MORES for men
Practical Considerations and Pitfalls
Accurate risk assessment depends on reliable input data and understanding score limitations.
- Weight measurement timing — Use your current weight, not historical or target weight. Recent significant weight loss artificially elevates risk scores. If weight has fluctuated substantially, consider using an average of recent months for the most representative assessment.
- Score thresholds are not diagnostic — Risk scores estimate probability, not certainty. A high score warrants bone density imaging (DEXA) but does not diagnose osteoporosis. Conversely, a low score does not exclude the condition in someone with relevant symptoms or risk concentrations.
- Medication and supplement blind spots — This calculator does not capture all contributors: long-term glucocorticoid use, anticonvulsants, certain cancer therapies, and calcium/vitamin D deficiency all raise risk but are not explicitly scored. Report these to your clinician.
- Ethnicity and bone density variation — Ethnic-specific bone density references exist because peak bone mass and fracture risk differ across populations. The SCORE system uses ethnicity as a proxy, but individual variation is substantial—use results as one input, not the sole determinant.
Interpreting Your Results and Next Steps
OST Score interpretation:
- Women: Score ≥1 indicates low risk; −3 to 1 is moderate risk; <−3 is high risk.
- Men: Score ≥3 indicates low risk; −1 to 3 is moderate risk; <−1 is high risk.
SCORE (women): Low risk <7 points; moderate risk 7–12; high risk >12.
MORES (men): Follows similar stratification with COPD weighted as an additional contributor.
A high-risk result warrants formal bone density testing via dual-energy X-ray absorptiometry (DEXA scan). Even moderate-risk individuals over 65 (women) or 70 (men) should discuss screening with their GP. Low-risk individuals benefit from bone-protective lifestyle measures: weight-bearing exercise, adequate calcium and vitamin D intake, smoking cessation, and limited alcohol consumption.